This week on The Bald Truth: Joe from Staten Island tells the TBT crew that they’re his only friends and admits that he’s not sure that having a sick kid would be worse than dealing with hair loss. UrlWallace from the IRC chat called the show to ask about his scalp Psoriasis, and George from Mobile checked in from an undisclosed location for his TBT update and probably to talk about being a former model.
Spencer Kobren’s The Bald Truth is internationally syndicated through the GFQ Network
The news has spread far and wide through the hair loss community that the Food and Drug Administration expanded their warning last Thursday on a group of drugs which includes finasteride (Proscar/Propecia), stating that using these drugs may increase the risk of high grade prostate cancer.
The latest warning indicates that 5 alpha reductase inhibitors (which include the hair loss drug Propecia) are linked to a greater risk of high grade prostate cancers. However, many physicians, including prostate cancer specialists, believe that these drugs actually improve the ability to detect aggressive tumors that already exist in patients, which can prove to be life saving.
According to Otis Brawley, M.D., chief medical officer and executive vice president of the American Cancer Society, this latest FDA warning has been misinterpreted by many and he felt it was important to set the record straight.
Spencer Kobren speaks with Dr. Otis Brawley of The American Cancer Society
IAHRS accepted hair transplant surgeon, Dr. James Harris is known worldwide for his role in the development of innovative technology that has helped to advance FUE surgical hair restoration to where it is today. Dr. Harris’ S.A.F.E. System is described as a three step process that utilizes both sharp and blunt instrumentation in order to rapidly and safely extract intact follicular units during the FUE process.
During the development of the ARTAS system, Restoration Robotics turned to Dr. Harris and his breakthrough FUE technology to further improve their already cutting edge follicular unit extracting system. According to those who have used the ARTAS system in practice, the result of merging these technologies is an incredibly efficient robotic tool, that so far has proven to significantly lower graft transection rates while improving the overall consistency of FUE hair transplant surgery.
>>Listen to Spencer Kobren’s Interview With Dr. James Harris
UK Show
Talk
News
